ABBOTT LABORATORIES·4

Sep 10, 6:13 PM ET

PEDERSON MICHAEL J 4

4 · ABBOTT LABORATORIES · Filed Sep 10, 2021

Insider Transaction Report

Form 4
Period: 2021-09-08
PEDERSON MICHAEL J
Senior Vice President
Transactions
  • Exercise/Conversion

    Common shares without par value

    2021-09-08$50.72/sh+23,008$1,166,96685,579 total
  • Exercise/Conversion

    Option (right to buy)

    2021-09-0823,0080 total
    Exercise: $50.72From: 2020-07-21Exp: 2027-07-20Common Shares (23,008 underlying)
  • Sale

    Common shares without par value

    2021-09-08$129.05/sh23,008$2,969,17362,571 total
Holdings
  • Common shares without par value

    (indirect: By Spouse)
    75
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.03 to $129.09, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Documents

1 file
  • 4
    form4-09102021_030923.xmlPrimary